1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow ICH - Intracerebral Hemorrhage: new trials by email Literature Review of ICH - Intracerebral Hemorrhage trials Research Report on ICH - Intracerebral Hemorrhage
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Minimally Invasive surgery (MIS), Deferoxamine, Standard Medical Care (SMD) - Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage | Phase 2 / Phase 3 | Not yet recruiting | University of Illinois at Chicago | 240 | 2026-03-01 | 2025-10-10 |
| Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage Pletaal 100mg/tab, Conventional internal medicine treatment - ICH - Intracerebral Hemorrhage | Phase 2 | Recruiting | National Taiwan University Hospital | 100 | 2025-06-16 | 2026-03-09 |
Brain Diseases (2) · Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Hemorrhage (2) · Intracranial Hemorrhages (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2)
Deferoxamine (1) · Minimally Invasive Surgical Procedures (1)
National Taiwan University Hospital (1) · University of Illinois at Chicago (1)
Taiwan (1) · United States (1)
Gursant S. Atwal, MD (1) · Hsin-Hsi Tsai, MD, PhD (1) · Javed Iqbal, MBBS (1)